Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
325 articles
Novel BRAF inhibitor mosperafenib demonstrates safety and efficacy in patients with advanced cancers, including those resistant to prior treatments.
Study reveals cancer can progress on imaging scans even when PSA levels remain stable, challenging current monitoring approaches.
New guidelines address how monetary transfers can ethically support cancer patients in clinical trials while avoiding coercion.
Scientists reveal how to reprogram immune cells that normally help tumors grow to instead become powerful cancer killers.
New research reveals how tumors hijack brain pathways through GDF15 protein to cause devastating weight loss in cancer patients.
New research reveals how successful chemotherapy creates special cells that enhance immune response and restrain tumor growth.
Researchers identify a common photoreceptor signature that unifies distinct brain tumors, revealing new therapeutic targets.
New research reveals how activating vascular STING pathways helps immune cells infiltrate and destroy aggressive lung cancer cells.
B7-H3-targeted therapy HS-20093 achieved 52% response rate in small cell lung cancer and 22% in non-small cell lung cancer patients.
Researchers propose guidelines to study how microbes within tumors influence cancer progression and treatment responses.
Major study reveals pediatric cancers have distinct genetic signatures that differ dramatically from adult cancers.
Researchers identify shared photoreceptor signature connecting aggressive pediatric brain tumors, opening new treatment paths.
